Spring direct naar de hoofdnavigatie of de inhoud
‘Patents can work for or against you. Creating your own patent portfolio, while mitigating the risks of your competitors’ IP rights, is essential for success in today’s technology-based economy.’
Tamara Elmore

Tamara Elmore

  • Life Sciences
  • European and Dutch Patent Attorney, European Patent Litigator
  • United States Patent Agent
  • Partner

Tamara Elmore is a Dutch and European patent attorney and a United States patent agent. She started her career at a large pharmaceutical company in Switzerland, before joining an IP office in Boston as a US patent agent. In 2009, she switched to V.O. where she is active as a patent attorney in the Chemistry & Life Sciences Department.

Continue reading

One of her goals is to provide clients with the information and analysis that will enable them to make informed business decisions over complex intellectual property matters.

Tamara’s focus is on obtaining patent protection for her clients’ inventions and strategically managing their patent portfolios. Additional aspects of her practice include patent validity and infringement analysis as well as IP due diligence.

In her capacity as European Patent Litigator, Tamara is allowed to act as UPC representative.

Working experience

  • Patent Attorney, V.O. (2009-present)
  • United States Patent Agent, Ropes & Gray (2006-2009)
  • European Patent Attorney trainee, Hoffman La-Roche (2005)
  • Post-doc, University of Zurich (2002 – 2004)

Education

  • Master in Intellectual Property, ETH, Zurich (2005)
  • PhD in Molecular Biology, University of Texas Southwestern (2002)
  • MSc in Zoology, Texas Tech University (1995)

Directories

  • Recognized as IP Star (2024, 2025) and ranked among the ‘Top 250 Women in IP’ (2023) by Managing Intellectual Property

Publications

  • Elmore T, Reach-through royalty provisions in licensing contracts; The Berkeley Electronic Press (bepress) 2005 http://www.bepress.com/ndsip/reports/art2
  • Elmore T, Ignell R, Carlson JR, Smith DP. Targeted mutation of a Drosophila odor receptor defines receptor requirement in a novel class of sensillum. J Neurosci. 2003 Oct 29;23(30):9906-12.
  • Elmore T, Smith DP. Putative Drosophila odor receptor OR43b localizes to dendrites of olfactory neurons. Insect Biochem Mol Biol. 2001 Jun 22;31(8):791-8.
  • Elmore T, Rodriguez A, Smith DP. dRGS7 encodes a Drosophila homolog of EGL-10 and vertebrate RGS7. DNA Cell Biol. 1998 Nov;17(11):983-9.

Languages

  • English

Also see these experts

Sara Calitz

Sara Calitz

  • European Patent Attorney
  • Associate
More experts

News

Camera-based “display visibility” as a technical security measure in remote gaming: T 2030/22 (Board 3.4.03)

In T 2030/22 (Board of Appeal 3.4.03, 27 November 2025) the Board overturned a refusal for lack of inventive step and addressed, in the same context, an examining division’s concerns that a key feature had no technical effect or was insufficiently disclosed. The decision is of practical interest where image-based recognition is used to control […]Continue reading

Patents as tickets to tax benefits

Both in the Netherlands and Belgium, innovation deductions offer significant tax benefits for companies investing in R&D. The Dutch Innovation Box works through a reduced tax rate on profits from innovation, while Belgium uses the innovation deduction to fully exempt a percentage of these profits. It pays for innovative companies to explore these opportunities.Continue reading

Urgency and standing in UPC preliminary injunction proceedings: UPC_CFI_374/2025 (Local Division The Hague)

In its order in UPC_CFI_374/2025, Local Division The Hague, 29 August 2025 (Cilag/Ethicon v RiVOLUTiON), the Court dismissed an application for provisional measures primarily on lack of temporal urgency under Rule 211.4 Rules of Procedure (RoP). The order is a detailed illustration of how the UPC assesses “unreasonable delay” in preliminary injunction (PI) practice and […]Continue reading